Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.810
+0.060 (3.43%)
At close: Dec 24, 2025, 1:00 PM EST
1.850
+0.040 (2.21%)
After-hours: Dec 24, 2025, 4:49 PM EST
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $307.59 million as of December 24, 2025. Its market cap has decreased by -81.64% in one year.
Market Cap
307.59M
Enterprise Value
156.15M
1-Year Change
-81.64%
Ranking
Category
Stock Price
$1.81
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $307.59M, a decrease of -88.09%. That is a compound annual growth rate of -60.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 307.59M | -82.04% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |